(c) 2023 PillSync.com

Temazepam 15 MG Oral Capsule

INDICATIONS & USAGE Temazepam Capsules, USP are indicated for the short-term treatment of insomnia (generally 7 to 10 days). For patients with short-term insomnia, instructions in the prescription should indicate that Temazepam Capsules should be used for short periods of time (7 to 10 days). The clinical trials performed in support of efficacy were 2 weeks in duration with the final formal assessment of sleep latency performed at the end of treatment.

PD-Rx Pharmaceuticals, Inc.

3 years ago CAPSULE WHITE 15 mg Novel 121 Temazepam 15 MG Oral Capsule

CAPSULE WHITE 15 mg Novel 121

3 years ago CAPSULE WHITE 15 mg Novel 121 Temazepam 15 MG Oral Capsule

15 mg Novel 121 CAPSULE WHITE

HOW SUPPLIED 15 mg blue opaque cap and white opaque body, imprinted “15 mg” on cap and “Novel 121” on the body in black ink. NDC 55289-196-14 Bottles of 14 NDC 55289-196-30 Bottles of 30 NDC 55289-196-60 Bottles of 60 NDC 55289-196-90 Bottles of 90 NDC 55289-196-01 Bottles of 100 NDC 55289-196-82 Bottles of 500 Dispense in a well-closed, light-resistant container with a child-resistant closure. Storage: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. *Romazicon is the registered trademark of Hoffman-LaRoche Inc. **Trademark of PDR Network, LLC

More pills like CAPSULE 15 mg Novel 121


"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site